CENTRAGARD® (eprinomectin and praziquantel transdermal solution)

Step into the
Next Generation
of Internal Parasite
Protection

CENTRAGARD^® (eprinomectin and praziquantel transdermal solution) is the first feline product to pair eprinomectin with praziquantel. The result is the first and only transdermal solution that prevents heartworm disease AND treats and controls internal parasites that can infect cats and kittens.

CENTRAGARD

Prevents heartworm disease

Treats & controls hookworms
(2 species: Ancylostoma tubaeforme and Ancylostoma braziliense)

Treats & controls roundworms
(Toxocara cati)

Treats & controls tapeworms
(2 species: Dipylidium caninum and Echinococcus multilocularis)

CENTRAGARD is approved for use on kittens as young as 7 weeks of age and weighing as little as 1.8 lbs. Plus, with an easy-to-use, stress-free applicator, it’s easier than ever to protect your patients.

For full product information, visit the Clinic Resources page and download the CENTRAGARD detailer.

Step into the Next Generation of Internal Parasite Protection

Step into the
Next Generation
of Internal Parasite
Protection